GURUFOCUS.COM » STOCK LIST » Basic Materials » Agriculture » Terragen Holdings Ltd (ASX:TGH) » Definitions » Notes Receivable

Terragen Holdings (ASX:TGH) Notes Receivable : A$0.00 Mil (As of Dec. 2023)


View and export this data going back to 2019. Start your Free Trial

What is Terragen Holdings Notes Receivable?

Terragen Holdings's Notes Receivable for the quarter that ended in Dec. 2023 was A$0.00 Mil.


Terragen Holdings Notes Receivable Historical Data

The historical data trend for Terragen Holdings's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Terragen Holdings Notes Receivable Chart

Terragen Holdings Annual Data
Trend Jun19 Jun20 Jun21 Jun22 Jun23
Notes Receivable
- - - - -

Terragen Holdings Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Notes Receivable Get a 7-Day Free Trial Premium Member Only - - - - -

Terragen Holdings Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.


Terragen Holdings Notes Receivable Related Terms

Thank you for viewing the detailed overview of Terragen Holdings's Notes Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


Terragen Holdings (ASX:TGH) Business Description

Traded in Other Exchanges
N/A
Address
39 Access Crescent, Unit 6, Coolum Beach, QLD, AUS, 4573
Terragen Holdings Ltd is an Australia based developer of agricultural bio solutions whose core technology platform addresses soil health and productivity, animal health and nutrition without relying on chemical-based fertilizers, pesticides and antibiotics. Its products include Mylo and Great Land Plus. Geographically, it operates within Australia and Newzealand.